Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Stratistics Market Research Consulting | PRODUCT CODE: 1371982

Cover Image

PUBLISHER: Stratistics Market Research Consulting | PRODUCT CODE: 1371982

Brain Mapping Instruments Market Forecasts to 2030 - Global Analysis By Product Type, End User and By Geography

PUBLISHED:
PAGES: 200+ Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
PDF (Single User License)
USD 4150
PDF (2-5 User License)
USD 5250
PDF & Excel (Site License)
USD 6350
PDF & Excel (Global Site License)
USD 7500

Add to Cart

According to Stratistics MRC, the Global Brain Mapping Instruments Market is accounted for $2.5 billion in 2023 and is expected to reach $4.2 billion by 2030 growing at a CAGR of 8.1% during the forecast period. The most accurate technique to detect and safeguard important brain regions while removing a tumor is through brain mapping. This operation may be necessary for patients whose tumors are close to the linguistic, motor, or sensory parts of the brain. Doctors have been able to remove as much of a brain tumor as feasible while limiting the effect on the vital regions of the brain that regulate movement, speech, and the senses.

According to the September 2021 update by the World Health Organization (WHO), about 55 million people worldwide were living with dementia in 2021, and nearly 10 million cases are reported every year.

Market Dynamics:

Driver:

Increase in neurological conditions

The prevalence of neurological disorders among the target population means that the use of brain mapping instruments in the medical device industry is likely to grow more rapidly, opening up new opportunities for the market for these tools. Additionally, the increased introduction of new products by several major players globally as a result of enhanced technology is anticipated to positively affect market growth.

Restraint:

High costs

The cost of purchasing and maintaining brain mapping equipment like MRI scanners, EEG systems, and MEG devices can be high. These instruments' high costs can be a constraint, especially for healthcare facilities with limited funds. The cost of the tools may prevent their widespread use, particularly in areas with limited resources.

Opportunity:

Technological development

The market for brain mapping instruments has a lot of potential due to the ongoing developments in brain imaging and mapping technology. In order to map brain activity more precisely, new imaging techniques, including functional magnetic resonance imaging (fMRI), electroencephalography (EEG), and magnetoencephalography (MEG), offer greater spatial and temporal resolution. Additionally, technology development has produced more complex and precise instruments for mapping the human brain. These technologies provide better data collection and analysis capacities, higher-quality images, and improved communication with other systems and devices. These advancements offer scientists and researchers a better understanding of how the brain works, how neural networks work, and how related illnesses work.

Threat:

Accessibility issues

Not all locations have equal access to brain mapping instruments, particularly rural and low-income nations. The accessibility and availability of brain mapping tools may be constrained by a lack of infrastructure, including healthcare facilities and competent workers. However, as it prevents the general adoption of these technologies, this restricted accessibility limits market expansion.

COVID-19 Impact:

An unexpected global public health emergency, COVID-19, has had an impact on practically every business. For instance, COVID-19 not only affects the respiratory system but also causes neurological and neuropsychiatric diseases, according to an article published in the Journal of Alzheimer's Diseases in December 2021. According to this, the virus may have an impact on the central nervous system (CNS), which could lead to cognitive impairment even after COVID-19 symptoms have subsided. As a result, people with COVID-19 developed worse neurological conditions. As a result, there was a need for brain mapping instruments, which had a major effect on market expansion during the epidemic.

The hospitals segment is expected to be the largest during the forecast period

Due to a rise in hospital admissions and product launches by the major market participants, the hospital segment dominated the largest share over the forecast period. The expansion of the market is also being fueled by the rising number of hospitals in the United States. According to numbers from the American Heart Association (AHA) released in January 2021, there were 1,228 investor-owned (for-profit) community hospitals in the United States in 2021, compared to 951 state and local government community hospitals. Moreover, the demand for brain mapping instruments is generated by the enormous number of hospitals, which is anticipated to fuel market expansion.

The Electroencephalography (EEG) segment is expected to have the highest CAGR during the forecast period

Due to its capabilities of using imaging techniques to diagnose brain illnesses, including epilepsy and seizures, the electroencephalography (EEG) segment is anticipated to have the highest CAGR throughout the projection period. Moreover, it is a method of diagnosis that aids in identifying alterations in the electrical activity of the brain. Therefore, it is promoting market expansion due to its quicker application process for detecting various brain challenges.

Region with largest share:

Due to the rising incidence of neurological illnesses, early acceptance of new technologies, and enhanced healthcare infrastructure in the US, North America currently holds a dominant position in the global market for brain mapping instruments. For instance, according to the Alzheimer's Association, in 2021, there were around 6.2 million Americans 65 and older who had Alzheimer's dementia, and that number is predicted to rise to 12.7 million by the year 2050. Moreover, the highly developed healthcare system and concentration on research and development provide a climate that is favorable to the adoption of cutting-edge technologies in the region. These elements are boosting the region's growth.

Region with highest CAGR:

Owing to growing health concerns and increased adoption of cutting-edge technologies, Asia-Pacific is anticipated to expand at a rapid pace over the course of the projected period. The NCBI reports that the rising prevalence of neurological illnesses in the area has led to an increase in neuroimaging investigations of brain structure and cognitive functioning. The treatment of individuals with brain illnesses has also adapted new methods, such as echo-planar imaging (EPI). The rapid MRI technique known as EPI can acquire MR images in a very short amount of time. As a result, the prevalence of brain illnesses and the adoption of cutting-edge technologies in the region have fueled market expansion.

Key players in the market:

Some of the key players in Brain Mapping Instruments market include: Advanced Brain Monitoring, Inc, Artinis Medical Systems, Canon Medical Systems Corp, General Electric Company, Gowerlabs Ltd, Koninklijke Philips N.V., Medtronic, Natus Medical Incorporated, Nihon Kohden Corporation, NIRx Medical Technologies, LLC, Siemens Healthcare Private Limited and Soterix Medical Inc.

Key Developments:

In September 2022, Scientists at the Allen Institute established the Brain Genome Project, a new global partnership to map approximately 200 billion cells in the human brain by type and function.

In March 2022, Kernel, a neurotechnology company, developed a wearable headset device, Kernel Flow, for brain measurement, which is based on time-domain functional near-infrared spectroscopy (TD-fNIRS). The device enables accurate, high-resolution measurement of the brain, and it functions by emitting picosecond pulses of light into tissue and measuring the arrival times of single photons.

Product Types Covered:

  • Magnetic Resonance Imaging (MRI)
  • Near-Infrared Spectroscopy (NIRS)
  • Electroencephalography (EEG)
  • Positron Emission Tomography (PET)
  • Computed Tomography
  • Other Product Types

End Users Covered:

  • Ambulatory Centers
  • Hospitals
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
Product Code: SMRC24038

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 End User Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Brain Mapping Instruments Market, By Product Type

  • 5.1 Introduction
  • 5.2 Magnetic Resonance Imaging (MRI)
  • 5.3 Near-Infrared Spectroscopy (NIRS)
  • 5.4 Electroencephalography (EEG)
  • 5.5 Positron Emission Tomography (PET)
  • 5.6 Computed Tomography
  • 5.7 Other Product Types

6 Global Brain Mapping Instruments Market, By End User

  • 6.1 Introduction
  • 6.2 Ambulatory Centers
  • 6.3 Hospitals
  • 6.8 Other End Users

7 Global Brain Mapping Instruments Market, By Geography

  • 7.1 Introduction
  • 7.2 North America
    • 7.2.1 US
    • 7.2.2 Canada
    • 7.2.3 Mexico
  • 7.3 Europe
    • 7.3.1 Germany
    • 7.3.2 UK
    • 7.3.3 Italy
    • 7.3.4 France
    • 7.3.5 Spain
    • 7.3.6 Rest of Europe
  • 7.4 Asia Pacific
    • 7.4.1 Japan
    • 7.4.2 China
    • 7.4.3 India
    • 7.4.4 Australia
    • 7.4.5 New Zealand
    • 7.4.6 South Korea
    • 7.4.7 Rest of Asia Pacific
  • 7.5 South America
    • 7.5.1 Argentina
    • 7.5.2 Brazil
    • 7.5.3 Chile
    • 7.5.4 Rest of South America
  • 7.6 Middle East & Africa
    • 7.6.1 Saudi Arabia
    • 7.6.2 UAE
    • 7.6.3 Qatar
    • 7.6.4 South Africa
    • 7.6.5 Rest of Middle East & Africa

8 Key Developments

  • 8.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 8.2 Acquisitions & Mergers
  • 8.3 New Product Launch
  • 8.4 Expansions
  • 8.5 Other Key Strategies

9 Company Profiling

  • 9.1 Advanced Brain Monitoring, Inc
  • 9.2 Artinis Medical Systems
  • 9.3 Canon Medical Systems Corp
  • 9.4 General Electric Company
  • 9.5 Gowerlabs Ltd
  • 9.6 Koninklijke Philips N.V.
  • 9.7 Medtronic
  • 9.8 Natus Medical Incorporated
  • 9.9 Nihon Kohden Corporation
  • 9.10 NIRx Medical Technologies, LLC
  • 9.11 Siemens Healthcare Private Limited
  • 9.12 Soterix Medical Inc
Product Code: SMRC24038

List of Tables

  • Table 1 Global Brain Mapping Instruments Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Brain Mapping Instruments Market Outlook, By Product Type (2021-2030) ($MN)
  • Table 3 Global Brain Mapping Instruments Market Outlook, By Magnetic Resonance Imaging (MRI) (2021-2030) ($MN)
  • Table 4 Global Brain Mapping Instruments Market Outlook, By Near-Infrared Spectroscopy (NIRS) (2021-2030) ($MN)
  • Table 5 Global Brain Mapping Instruments Market Outlook, By Electroencephalography (EEG) (2021-2030) ($MN)
  • Table 6 Global Brain Mapping Instruments Market Outlook, By Positron Emission Tomography (PET) (2021-2030) ($MN)
  • Table 7 Global Brain Mapping Instruments Market Outlook, By Computed Tomography (2021-2030) ($MN)
  • Table 8 Global Brain Mapping Instruments Market Outlook, By Other Product Types (2021-2030) ($MN)
  • Table 9 Global Brain Mapping Instruments Market Outlook, By End User (2021-2030) ($MN)
  • Table 10 Global Brain Mapping Instruments Market Outlook, By Ambulatory Centers (2021-2030) ($MN)
  • Table 11 Global Brain Mapping Instruments Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 12 Global Brain Mapping Instruments Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 13 North America Brain Mapping Instruments Market Outlook, By Country (2021-2030) ($MN)
  • Table 14 North America Brain Mapping Instruments Market Outlook, By Product Type (2021-2030) ($MN)
  • Table 15 North America Brain Mapping Instruments Market Outlook, By Magnetic Resonance Imaging (MRI) (2021-2030) ($MN)
  • Table 16 North America Brain Mapping Instruments Market Outlook, By Near-Infrared Spectroscopy (NIRS) (2021-2030) ($MN)
  • Table 17 North America Brain Mapping Instruments Market Outlook, By Electroencephalography (EEG) (2021-2030) ($MN)
  • Table 18 North America Brain Mapping Instruments Market Outlook, By Positron Emission Tomography (PET) (2021-2030) ($MN)
  • Table 19 North America Brain Mapping Instruments Market Outlook, By Computed Tomography (2021-2030) ($MN)
  • Table 20 North America Brain Mapping Instruments Market Outlook, By Other Product Types (2021-2030) ($MN)
  • Table 21 North America Brain Mapping Instruments Market Outlook, By End User (2021-2030) ($MN)
  • Table 22 North America Brain Mapping Instruments Market Outlook, By Ambulatory Centers (2021-2030) ($MN)
  • Table 23 North America Brain Mapping Instruments Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 24 North America Brain Mapping Instruments Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 25 Europe Brain Mapping Instruments Market Outlook, By Country (2021-2030) ($MN)
  • Table 26 Europe Brain Mapping Instruments Market Outlook, By Product Type (2021-2030) ($MN)
  • Table 27 Europe Brain Mapping Instruments Market Outlook, By Magnetic Resonance Imaging (MRI) (2021-2030) ($MN)
  • Table 28 Europe Brain Mapping Instruments Market Outlook, By Near-Infrared Spectroscopy (NIRS) (2021-2030) ($MN)
  • Table 29 Europe Brain Mapping Instruments Market Outlook, By Electroencephalography (EEG) (2021-2030) ($MN)
  • Table 30 Europe Brain Mapping Instruments Market Outlook, By Positron Emission Tomography (PET) (2021-2030) ($MN)
  • Table 31 Europe Brain Mapping Instruments Market Outlook, By Computed Tomography (2021-2030) ($MN)
  • Table 32 Europe Brain Mapping Instruments Market Outlook, By Other Product Types (2021-2030) ($MN)
  • Table 33 Europe Brain Mapping Instruments Market Outlook, By End User (2021-2030) ($MN)
  • Table 34 Europe Brain Mapping Instruments Market Outlook, By Ambulatory Centers (2021-2030) ($MN)
  • Table 35 Europe Brain Mapping Instruments Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 36 Europe Brain Mapping Instruments Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 37 Asia Pacific Brain Mapping Instruments Market Outlook, By Country (2021-2030) ($MN)
  • Table 38 Asia Pacific Brain Mapping Instruments Market Outlook, By Product Type (2021-2030) ($MN)
  • Table 39 Asia Pacific Brain Mapping Instruments Market Outlook, By Magnetic Resonance Imaging (MRI) (2021-2030) ($MN)
  • Table 40 Asia Pacific Brain Mapping Instruments Market Outlook, By Near-Infrared Spectroscopy (NIRS) (2021-2030) ($MN)
  • Table 41 Asia Pacific Brain Mapping Instruments Market Outlook, By Electroencephalography (EEG) (2021-2030) ($MN)
  • Table 42 Asia Pacific Brain Mapping Instruments Market Outlook, By Positron Emission Tomography (PET) (2021-2030) ($MN)
  • Table 43 Asia Pacific Brain Mapping Instruments Market Outlook, By Computed Tomography (2021-2030) ($MN)
  • Table 44 Asia Pacific Brain Mapping Instruments Market Outlook, By Other Product Types (2021-2030) ($MN)
  • Table 45 Asia Pacific Brain Mapping Instruments Market Outlook, By End User (2021-2030) ($MN)
  • Table 46 Asia Pacific Brain Mapping Instruments Market Outlook, By Ambulatory Centers (2021-2030) ($MN)
  • Table 47 Asia Pacific Brain Mapping Instruments Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 48 Asia Pacific Brain Mapping Instruments Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 49 South America Brain Mapping Instruments Market Outlook, By Country (2021-2030) ($MN)
  • Table 50 South America Brain Mapping Instruments Market Outlook, By Product Type (2021-2030) ($MN)
  • Table 51 South America Brain Mapping Instruments Market Outlook, By Magnetic Resonance Imaging (MRI) (2021-2030) ($MN)
  • Table 52 South America Brain Mapping Instruments Market Outlook, By Near-Infrared Spectroscopy (NIRS) (2021-2030) ($MN)
  • Table 53 South America Brain Mapping Instruments Market Outlook, By Electroencephalography (EEG) (2021-2030) ($MN)
  • Table 54 South America Brain Mapping Instruments Market Outlook, By Positron Emission Tomography (PET) (2021-2030) ($MN)
  • Table 55 South America Brain Mapping Instruments Market Outlook, By Computed Tomography (2021-2030) ($MN)
  • Table 56 South America Brain Mapping Instruments Market Outlook, By Other Product Types (2021-2030) ($MN)
  • Table 57 South America Brain Mapping Instruments Market Outlook, By End User (2021-2030) ($MN)
  • Table 58 South America Brain Mapping Instruments Market Outlook, By Ambulatory Centers (2021-2030) ($MN)
  • Table 59 South America Brain Mapping Instruments Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 60 South America Brain Mapping Instruments Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 61 Middle East & Africa Brain Mapping Instruments Market Outlook, By Country (2021-2030) ($MN)
  • Table 62 Middle East & Africa Brain Mapping Instruments Market Outlook, By Product Type (2021-2030) ($MN)
  • Table 63 Middle East & Africa Brain Mapping Instruments Market Outlook, By Magnetic Resonance Imaging (MRI) (2021-2030) ($MN)
  • Table 64 Middle East & Africa Brain Mapping Instruments Market Outlook, By Near-Infrared Spectroscopy (NIRS) (2021-2030) ($MN)
  • Table 65 Middle East & Africa Brain Mapping Instruments Market Outlook, By Electroencephalography (EEG) (2021-2030) ($MN)
  • Table 66 Middle East & Africa Brain Mapping Instruments Market Outlook, By Positron Emission Tomography (PET) (2021-2030) ($MN)
  • Table 67 Middle East & Africa Brain Mapping Instruments Market Outlook, By Computed Tomography (2021-2030) ($MN)
  • Table 68 Middle East & Africa Brain Mapping Instruments Market Outlook, By Other Product Types (2021-2030) ($MN)
  • Table 69 Middle East & Africa Brain Mapping Instruments Market Outlook, By End User (2021-2030) ($MN)
  • Table 70 Middle East & Africa Brain Mapping Instruments Market Outlook, By Ambulatory Centers (2021-2030) ($MN)
  • Table 71 Middle East & Africa Brain Mapping Instruments Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 72 Middle East & Africa Brain Mapping Instruments Market Outlook, By Other End Users (2021-2030) ($MN)
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!